{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31571568", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.4269/ajtmh.19-0350"], "Journal": {"ISSN": "1476-1645", "JournalIssue": {"Volume": "101", "Issue": "6", "PubDate": {"Year": "2019", "Month": "Dec"}}, "Title": "The American journal of tropical medicine and hygiene", "ISOAbbreviation": "Am J Trop Med Hyg"}, "ArticleTitle": "Vismione B Interferes with <i>Trypanosoma cruzi</i> Infection of Vero Cells and Human Stem Cell-Derived Cardiomyocytes.", "Pagination": {"StartPage": "1359", "EndPage": "1368", "MedlinePgn": "1359-1368"}, "Abstract": {"AbstractText": ["Traditional African medicine is a source of new molecules that might be useful in modern therapeutics. We tested ten limonoids, six quinones, one xanthone, one alkaloid, and one cycloartane, isolated from four Cameroonian medicinal plants, and one plant-associated endophytic fungus, against <i>Trypanosoma cruzi</i>, the etiological agent of Chagas disease (CD). Vero cells, or human-induced pluripotent stem cells (hiPSC)-derived cardiomyocytes (hiPSC-CM) were infected with <i>T. cruzi</i> trypomastigotes (discrete typing unit types I or II). Infection took place in the presence of drugs, or 24 hours before drug treatment. Forty-eight hours after infection, infection rates and parasite multiplication were evaluated by Giemsa stain. Cell metabolism was measured to determine functional integrity. In Vero cells, several individual molecules significantly affected <i>T. cruzi</i> infection and multiplication with no, or minor, effects on cell viability. Reduced infection rates and multiplication by the quinone vismione B was superior to the commonly used therapeutic benznidazole (BNZ). The vismione B concentration inhibiting 50% of <i>T. cruzi</i> infection (IC<sub>50</sub>) was 1.3 \u00b5M. When drug was applied after infection, anti-<i>Trypanosoma</i> effects of vismione B [10 \u00b5M) were significantly stronger than effects of BNZ (23 \u00b5M). Furthermore, in hiPSC-CM cultures, infection and multiplication rates in the presence of vismione B (10 \u00b5M) were significantly lower than in BNZ (11.5 \u00b5M), without showing signs of cytotoxicity. Our data indicate that vismione B is more potent against <i>T. cruzi</i> infection and multiplication than BNZ, with stronger effects on established infection. Vismione B, therefore, might become a promising lead molecule for treatment development for CD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "California Institute for Medical Research, San Jose, California."}], "LastName": "Sass", "ForeName": "Gabriele", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Tsamo", "ForeName": "Armelle T", "Initials": "AT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Chounda", "ForeName": "Gwladys A M", "Initials": "GAM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Nangmo", "ForeName": "Pamela K", "Initials": "PK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Department of Medicine, School of Medicine, Stanford University, Stanford, California."}], "LastName": "Sayed", "ForeName": "Nazish", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "California Institute for Medical Research, San Jose, California."}, {"Identifier": [], "Affiliation": "Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Institute of Research Ren\u00e9 Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil."}, {"Identifier": [], "Affiliation": "Department of Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Department of Radiology, School of Medicine, Stanford University, Stanford, California."}], "LastName": "Bozzi", "ForeName": "Adriana", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Department of Radiology, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California."}, {"Identifier": [], "Affiliation": "Department of Medicine, School of Medicine, Stanford University, Stanford, California."}], "LastName": "Wu", "ForeName": "Joseph C", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Nkengfack", "ForeName": "Augustin E", "Initials": "AE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Research Ren\u00e9 Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil."}, {"Identifier": [], "Affiliation": "California Institute for Medical Research, San Jose, California."}], "LastName": "Stevens", "ForeName": "David A", "Initials": "DA"}], "GrantList": [{"GrantID": "R01 HL141371", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL141851", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K01 HL135455", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Trop Med Hyg", "NlmUniqueID": "0370507", "ISSNLinking": "0002-9637"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anthracenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Trypanocidal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "vismione B"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anthracenes"}, {"QualifierName": [], "DescriptorName": "Cameroon"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["parasitology"], "DescriptorName": "Myocytes, Cardiac"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["parasitology"], "DescriptorName": "Stem Cells"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Trypanocidal Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trypanosoma cruzi"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "World Health Organization , 2015. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 90: 33\u201344.", "ArticleIdList": ["25671846"]}, {"Citation": "Bern C, Kjos S, Yabsley MJ, Montgomery SP, 2011. Trypanosoma cruzi and Chagas\u2019 disease in the United States. Clin Microbiol Rev 24: 655\u2013681.", "ArticleIdList": ["PMC3194829", "21976603"]}, {"Citation": "Bern C, Montgomery SP, 2009. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52\u2013e54.", "ArticleIdList": ["19640226"]}, {"Citation": "Jurberg C, 2009. Chagas: one hundred years later. Bull World Health Organ 87: 491\u2013492.", "ArticleIdList": ["PMC2704045", "19649360"]}, {"Citation": "Kirchhoff LV, 2011. Epidemiology of American trypanosomiasis (Chagas disease). Adv Parasitol 75: 1\u201318.", "ArticleIdList": ["21820549"]}, {"Citation": "Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M, 1992. Chagas\u2019 disease. Clin Microbiol Rev 5: 400\u2013419.", "ArticleIdList": ["PMC358257", "1423218"]}, {"Citation": "Coura JR, Vinas PA, 2010. Chagas disease: a new worldwide challenge. Nature 465: S6\u2013S7.", "ArticleIdList": ["20571554"]}, {"Citation": "Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ, 2016. Estimating the burden of Chagas disease in the United States. PLoS Negl Trop Dis 10: e0005033.", "ArticleIdList": ["PMC5098725", "27820837"]}, {"Citation": "Brown EL, Roellig DM, Gompper ME, Monello RJ, Wenning KM, Gabriel MW, Yabsley MJ, 2010. Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the southern United States. Vector Borne Zoonotic Dis 10: 757\u2013763.", "ArticleIdList": ["PMC2976638", "20020815"]}, {"Citation": "Zingales B, et al. 2012. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol 12: 240\u2013253.", "ArticleIdList": ["22226704"]}, {"Citation": "Vago AR, Andrade LO, Leite AA, d'Avila Reis D, Macedo AM, Adad SJ, Tostes S, Jr., Moreira MC, Filho GB, Pena SD, 2000. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 156: 1805\u20131809.", "ArticleIdList": ["PMC1876933", "10793092"]}, {"Citation": "Sales Junior PA, Molina I, Fonseca Murta SM, S\u00e1nchez-Montalv\u00e1 A, Salvador F, Corr\u00eaa-Oliveira R, Carneiro CM, 2017. Experimental and clinical treatment of Chagas Disease: a review. Am J Trop Med Hyg 97: 1289\u20131303.", "ArticleIdList": ["PMC5817734", "29016289"]}, {"Citation": "de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, de Andrade SS, de Andrade JG, Martelli CM, 1996. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348: 1407\u20131413.", "ArticleIdList": ["8937280"]}, {"Citation": "Fragata Filho AA, da Silva MA, Boainain E, 1995. Ethiologic treatment of acute and chronic Chagas\u2019 disease [corrected]. Sao Paulo Med J 113: 867\u2013872.", "ArticleIdList": ["8650489"]}, {"Citation": "Urbina JA, 2010. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115: 55\u201368.", "ArticleIdList": ["19900395"]}, {"Citation": "Louppe D, 2008. PROTA (Plant resources of tropical Africa), Paris, France. Vol. 8: 758."}, {"Citation": "Pupo MT, Vieira PC, Fernandes JB, Silva MFGF, Pirani JR, 2002. Terpenoids and steroids from Trichilia species. J Braz Chem Soc 13: 382\u2013388."}, {"Citation": "Fobofou SAT, Franke K, Schmidt J, Wessjohann L, 2015. Chemical constituents of Psorospermum densipunctatum (Hypericaceae). Biochem Syst Ecol 59: 174\u2013176."}, {"Citation": "Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL, 2010. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 51: 690\u2013698.", "ArticleIdList": ["PMC2930399", "20101751"]}, {"Citation": "Armelle TT, Pamela NK, Pierre M, M\u00fcller IB, Marat K, Sass G, Ephrem NA, 2016. Antiplasmodial limonoids from Trichilia rubescens (Meliaceae). Med Chem 12: 655\u2013661.", "ArticleIdList": ["26732117"]}, {"Citation": "Lange N, Tontsa AT, Wegscheid C, Mkounga P, Nkengfack AE, Loscher C, Sass G, Tiegs G, 2016. The limonoids TS3 and Rubescin E induce apoptosis in human hepatoma cell lines and interfere with NF-\u03baB signaling. PLoS One 11: e0160843.", "ArticleIdList": ["PMC4982607", "27518192"]}, {"Citation": "Kemegne GA, Mkounga P, Essia Ngang JJ, Sado Kamdem SL, Nkengfack AE, 2017. Antimicrobial structure activity relationship of five anthraquinones of emodine type isolated from Vismia laurentii. BMC Microbiol 17: 41.", "ArticleIdList": ["PMC5322612", "28228111"]}, {"Citation": "Krief S, Martin MT, Grellier P, Kasenene J, S\u00e9venet T, 2004. Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda. Antimicrob Agents Chemother 48: 3196\u20133319.", "ArticleIdList": ["PMC478548", "15273150"]}, {"Citation": "Tsamo Tontsa A, Mkounga P, Njayou FN, Manautou J, Kirk M, Hultin PG, Nkengfack AE, 2013. Rubescins A, B and C: new havanensin type limonoids from root bark of Trichilia rubescens (Meliaceae). Chem Pharm Bull (Tokyo) 61: 1178\u20131183.", "ArticleIdList": ["24189305"]}, {"Citation": "Tsamo AT, Pagna JIM, Nangmo PK, Mkounga P, Laatsch H, Nkengfack AE, 2019. Rubescins F-H, new vilasinin-type limonoids from the leaves of Trichilia rubescens (Meliaceae). Z Naturforsch C 74: 175\u2013182.", "ArticleIdList": ["30903762"]}, {"Citation": "deCarvalho AC, Ndi CP, Tsopmo A, Tane P, Ayafor J, Connolly JD, Teem JL, 2002. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508. Mol Med 8: 75\u201387.", "ArticleIdList": ["PMC2039976", "12080183"]}, {"Citation": "Aldridge DC, Turner WB, 1969. The identity of zygosporin A and cytochalasin D. J Antibiot (Tokyo) 22: 170.", "ArticleIdList": ["5800426"]}, {"Citation": "Morrison TG, McGinnes LJ, 1985. Cytochalasin D accelerates the release of Newcastle disease virus from infected cells. Virus Res 4: 93\u2013106.", "ArticleIdList": ["4082779"]}, {"Citation": "Nangmo KP, Akone SH, Tsamo TA, Zhen L, Mueller WEG, Proksch P, Nkengfack AE, 2017. Colletotrin: a sesquiterpene lactone from the endophytic fungus Colletotrichum gloeosporioides associated with Trichilia monadelpha. Z Naturforsch B 72: 697\u2013703."}, {"Citation": "Nangmo KP, Tsamo TA, Zhen L, Mkounga P, Akone SH, Tsabang N, Muller WEG, Proksch P, Nkengfack AE, 2018. Chemical constituents from leaves and root bark of Trichilia monadelpha (Meliaceae). Phytochem Lett 23: 120\u2013126."}, {"Citation": "Dzoyem JP, Tsamo AT, Melong R, Mkounga P, Nkengfack AE, McGaw LJ, Eloff JN, 2015. Cytotoxicity, nitric oxide and acetylcholinesterase inhibitory activity of three limonoids isolated from Trichilia welwitschii (Meliaceae). Biol Res 48: 57.", "ArticleIdList": ["PMC4604621", "26463660"]}, {"Citation": "Tsamo A, Langat MK, Nkounga P, Waffo AFK, Nkengfack AE, Mulhollan DA, 2013. Limonoids from the west African Trichilia welwitschii (Meliaceae). Biochem Syst Ecol 50: 368\u2013370."}, {"Citation": "Brader G, Vajrodaya S, Greger H, Bacher M, Kalchhauser H, Hofer O, 1998. Bisamides, lignans, triterpenes, and insecticidal cyclopenta[b]benzofurans from Aglaia species. J Nat Prod 61: 1482\u20131490.", "ArticleIdList": ["9868148"]}, {"Citation": "Hussein AA, Bozzi B, Correa M, Capson TL, Kursar TA, Coley PD, Solis PN, Gupta MP, 2003. Bioactive constituents from three Vismia species. J Nat Prod 66: 858\u2013860.", "ArticleIdList": ["12828475"]}, {"Citation": "Delle Monache F, Botta B, Delle Monache G, Marini Bettolo GB, 1985. Prenylated anthranoids from Psorospermum species. Phytochemistry 24: 1855\u20131856."}, {"Citation": "Reyes-Chilpa R, G\u00f3mez-Cansino R, Guzm\u00e1n-Guti\u00e9rrez SL, Hern\u00e1ndez-Ortega S, Campos-Lara M, Vega-Avila E, Nieto-Camacho A, 2014. Anthraquinones from Vismia mexicana. Z Naturforsch C 69: 29\u201334.", "ArticleIdList": ["24772820"]}, {"Citation": "De Oliveira WG, Lins Mesquita AA, de Lima RA, Gotlieb OR, Gottlieb HE, 1984. Xanthones from Tovomita excelsa. Phytochemistry 23: 2390\u20132391."}, {"Citation": "Churko JM, Burridge PW, Wu JC, 2013. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol 1036: 81\u201388.", "ArticleIdList": ["PMC6430631", "23807788"]}, {"Citation": "Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP, 2012. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 109: E1848\u2013E1857.", "ArticleIdList": ["PMC3390875", "22645348"]}, {"Citation": "Andrade D, et al. 2012. Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy. Br J Pharmacol 165: 1333\u20131347.", "ArticleIdList": ["PMC3372720", "21797847"]}, {"Citation": "Burridge PW, et al. 2014. Chemically defined generation of human cardiomyocytes. Nat Methods 11: 855\u2013860.", "ArticleIdList": ["PMC4169698", "24930130"]}, {"Citation": "Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR, 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827\u20134833.", "ArticleIdList": ["3409223"]}, {"Citation": "Richle RW, Raaflaub J, 1980. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results. Acta Trop 37: 257\u2013261.", "ArticleIdList": ["6106364"]}, {"Citation": "Coura JR, de Castro SL, 2002. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3\u201324.", "ArticleIdList": ["11992141"]}, {"Citation": "Murta AC, Persechini PM, Padron Tde S, de Souza W, Guimar\u00e3es JA, Scharfstein J, 1990. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol Biochem Parasitol 43: 27\u201338.", "ArticleIdList": ["1705310"]}, {"Citation": "Sueth-Santiago V, Decote-Ricardo D, Morrot A, Freire-de-Lima CG, Lima ME, 2017. Challenges in the chemotherapy of Chagas disease: looking for possibilities related to the differences and similarities between the parasite and host. World J Biol Chem 8: 57\u201380 [Review].", "ArticleIdList": ["PMC5329715", "28289519"]}, {"Citation": "Clemons KV, Sobel RA, Martinez M, Correa Oliveira R, Stevens DA, 2017. Lack of efficacy of liposomal amphotericin B against acute and chronic Trypanosoma cruzi infection in mice. Am J Trop Med Hyg 97: 1141\u20131146.", "ArticleIdList": ["PMC5637596", "28820684"]}, {"Citation": "Sass G, Madigan RT, Joubert LM, Bozzi A, Sayed N, Wu JC, Stevens DA, 2019. A combination of itraconazole and amiodarone is highly effective against Trypanosoma cruzi infection of human stem cell-derived cardiomyocytes. Am J Trop Med Hyg 101: 383\u2013391.", "ArticleIdList": ["PMC6685576", "31219005"]}, {"Citation": "Hoet S, St\u00e9vigny C, Block S, Opperdoes F, Colson P, Baldeyrou B, Lansiaux A, Bailly C, Quetin-Leclercq J, 2004. Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases. Planta Med 70: 407\u2013413.", "ArticleIdList": ["15124084"]}, {"Citation": "Wube AA, Bucar F, Gibbons S, Asres K, Rattray L, Croft SL, 2010. Antiprotozoal activity of drimane and coloratane sesquiterpenes towards Trypanosoma brucei rhodesiense and Plasmodium falciparum in vitro. Phytother Res 24: 1468\u20131472.", "ArticleIdList": ["20878696"]}, {"Citation": "Nwodo N, Okoye F, Lai D, Debbab A, Kaiser M, Brun R, Proksch P, 2015. Evaluation of the in vitro trypanocidal activity of methylated flavonoid constituents of Vitex simplicifolia leaves. BMC Complement Altern Med 15: 82.", "ArticleIdList": ["PMC4384300", "25886869"]}, {"Citation": "Nwodo NJ, Okoye FB, Lai D, Debbab A, Brun R, Proksch P, 2014. Two trypanocidal dipeptides from the roots of Zapoteca portoricensis (Fabaceae). Molecules 19: 5470\u20135477.", "ArticleIdList": ["PMC6270954", "24776813"]}, {"Citation": "Githua M, Hassanali A, Keriko J, Murilla G, Ndungu M, Nyagah G, 2010. New antitrypanosomal tetranotriterpenoids from Azadirachta indica. Afr J Tradit Complement Altern Med 7: 207\u2013213.", "ArticleIdList": ["PMC3025624", "21461147"]}, {"Citation": "Leite AC, Ambrozin AR, Fernandes JB, Vieira PC, da Silva MF, de Albuquerque S, 2008. Trypanocidal activity of limonoids and triterpenes from Cedrela fissilis. Planta Med 74: 1795\u20131799.", "ArticleIdList": ["18991203"]}, {"Citation": "Laphookhieo S, Maneerat W, Koysomboon S, 2009. Antimalarial and cytotoxic phenolic compounds from Cratoxylum maingayi and Cratoxylum cochinchinense. Molecules 14: 1389\u20131395.", "ArticleIdList": ["PMC6254373", "19384270"]}, {"Citation": "Duran-Rehbein GA, Vargas-Zambrano JC, Cu\u00e9llar A, Puerta CJ, Gonzalez JM, 2014. Mammalian cellular culture models of Trypanosoma cruzi infection: a review of the published literature. Parasite 21: 38 [Review].", "ArticleIdList": ["PMC4118624", "25083732"]}, {"Citation": "Piras MM, Piras R, Henriquez D, Negri S, 1982. Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol 6: 67\u201381.", "ArticleIdList": ["6182466"]}, {"Citation": "Todorov AG, et al. 2003. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J 17: 73\u201375.", "ArticleIdList": ["12424228"]}, {"Citation": "Bozzi A, Sayed N, Matsa E, Sass G, Neofytou E, Clemons KV, Correa-Oliveira R, Stevens DA, Wu JC, 2019. Using human induced pluripotent stem cell-derived cardiomyocytes as a model to study Trypanosoma cruzi infection. Stem Cell Rep 12: 1232\u20131241.", "ArticleIdList": ["PMC6565757", "31105048"]}, {"Citation": "Gutteridge WE, Knowler J, Coombes JD, 1969. Growth of Trypanosoma cruzi in human heart tissue cells and effects of aminonucleoside of puromycin, trypacidin and aminopterin. J Protozool 16: 521\u2013525.", "ArticleIdList": ["5343467"]}, {"Citation": "da Silva Lara L, Andrade-Lima L, Calvet CM, Borsoi J, Alberto Duque TL, Henriques-Pons A, Souza Pereira MC, Pereira LV, 2018. Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease. Microbes Infect 20: 312\u2013316.", "ArticleIdList": ["29577969"]}, {"Citation": "Valenzuela L, Sep\u00falveda S, Ponce I, Galanti N, Cabrera G, 2018. The overexpression of TcAP1 endonuclease confers resistance to infective Trypanosoma cruzi trypomastigotes against oxidative DNA damage. J Cell Biochem 119: 5985\u20135995.", "ArticleIdList": ["29575156"]}, {"Citation": "Finzi JK, Chiavegatto CW, Corat KF, Lopez JA, Cabrera OG, Mielniczki-Pereira AA, Colli W, Alves MJ, Gadelha FR, 2004. Trypanosoma cruzi response to the oxidative stress generated by hydrogen peroxide. Mol Biochem Parasitol 133: 37\u201343.", "ArticleIdList": ["14668010"]}, {"Citation": "Li DL, Li XM, Wang BG, 2009. Natural anthraquinone derivatives from a marine mangrove plant-derived endophytic fungus Eurotium rubrum: structural elucidation and DPPH radical scavenging activity. J Microbiol Biotechnol 19: 675\u2013680.", "ArticleIdList": ["19652514"]}, {"Citation": "Aviello G, Rowland I, Gill CI, Acquaviva AM, Capasso F, McCann M, Capasso R, Izzo AA, Borrelli F, 2010. Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells. J Cell Mol Med 14: 2006\u20132014.", "ArticleIdList": ["PMC3823282", "19538468"]}, {"Citation": "Garcia MN, Burroughs H, Gorchakov R, Gunter SM, Dumonteil E, Murray KO, Herrera CP, 2017. Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA. Infect Genet Evol 49: 151\u2013156.", "ArticleIdList": ["28095298"]}, {"Citation": "Mbwambo ZH, Apers S, Moshi MJ, Kapingu MC, Van Miert S, Claeys M, Brun R, Cos P, Pieters L, Vlietinck A, 2004. Anthranoid compounds with antiprotozoal activity from Vismia orientalis. Planta Med 70: 706\u2013710.", "ArticleIdList": ["15368649"]}, {"Citation": "Cassinelli G, Geroni C, Botta B, delle Monache G, delle Monache F, 1986. Cytotoxic and antitumor activity of vismiones isolated from vismieae. J Nat Prod 49: 929\u2013931.", "ArticleIdList": ["3819736"]}, {"Citation": "Tewabe Y, Bisrat D, Terefe G, Asres K, 2014. Antitrypanosomal activity of aloin and its derivatives against Trypanosoma congolense field isolate. BMC Vet Res 10: 61.", "ArticleIdList": ["PMC3984735", "24612613"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31571568", "PMC6896885", "10.4269/ajtmh.19-0350"]}}]}